Helper-independent piggyBac plasmids for gene delivery approaches: strategies for avoiding potential genotoxic effects.
Efficient integration of functional genes is an essential prerequisite for successful gene delivery such as cell transfection, animal transgenesis, and gene therapy. Gene delivery strategies based on viral vectors are currently the most efficient. However, limited cargo capacity, host immune response, and the risk of insertional mutagenesis are limiting factors and of concern. Recently, several groups have used transposon-based approaches to deliver genes to a variety of cells. The piggyBac (pB) transposase in particular has been shown to be well suited for cell transfection and gene therapy approaches because of its flexibility for molecular modification, large cargo capacity, and high transposition activity. However, safety considerations regarding transposase gene insertions into host genomes have rarely been addressed. Here we report our results on engineering helper-independent pB plasmids. The single-plasmid gene delivery system carries both the piggyBac transposase (pBt) expression cassette as well as the transposon cargo flanked by terminal repeat element sequences. Improvements to the helper-independent structure were achieved by developing new plasmids in which the pBt gene is rendered inactive after excision of the transposon from the plasmid. As a consequence, potentially negative effects that may develop by the persistence of an active pBt gene posttransposition are eliminated. The results presented herein demonstrate that our helper-independent plasmids represent an important step in the development of safe and efficient gene delivery methods that should prove valuable in gene therapy and transgenic approaches.
Urschitz
Johann
J
Department of Anatomy, John A Burns School of Medicine, Honolulu, HI 96822, USA.
Kawasumi
Miyuri
M
Owens
Jesse
J
Morozumi
Kazuto
K
Yamashiro
Hideaki
H
Stoytchev
Ilko
I
Marh
Joel
J
Dee
James A
JA
Kawamoto
Kris
K
Coates
Craig J
CJ
Kaminski
Joseph M
JM
Pelczar
Pawel
P
Yanagimachi
Ryuzo
R
Moisyadi
Stefan
S
D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D004249:DNA Damage; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D051379:Mice; D010957:Plasmids / Q000235:genetics*; D019895:Transposases / Q000235:genetics*
D019895:Transposases
Genesis. 2009 Jun;47(6):404-8
19391106
FASEB J. 2006 Sep;20(11):1880-2
16877528
Reprod Nutr Dev. 1996;36(6):607-18
9021872
Reprod Nutr Dev. 2001 Nov-Dec;41(6):465-85
12126294
Mol Ther. 2006 Mar;13(3):625-30
16368272
Mol Ther. 2010 Oct;18(10):1796-802
20628359
Mol Biol Med. 1989 Aug;6(4):283-98
2695741
Cancer Res. 2008 Apr 15;68(8):2961-71
18413766
Nat Genet. 2009 Jun;41(6):753-61
19412179
EMBO J. 2008 Apr 9;27(7):1097-109
18354502
Nature. 2009 Apr 9;458(7239):766-70
19252478
Mol Ther. 2007 Jan;15(1):139-45
17164785
Hum Gene Ther. 1999 Apr 10;10(6):965-76
10223730
Genome Res. 2009 Apr;19(4):667-73
19233961
Transgenic Res. 2007 Jun;16(3):333-9
17340207
Nat Med. 2001 Jan;7(1):33-40
11135613
Nat Biotechnol. 2003 May;21(5):492-3
12721569
Nucleic Acids Res. 2007;35(12):e87
17576687
Stem Cells Dev. 2010 Jun;19(6):763-71
19740021
J Immunother. 2009 Oct;32(8):837-44
19752750
Biol Reprod. 2006 Nov;75(5):785-91
16899651
Insect Mol Biol. 1996 May;5(2):141-51
8673264
Hepatology. 2009 Sep;50(3):815-24
19585550
FASEB J. 2002 Aug;16(10):1242-7
12153992
Biol Reprod. 2005 Dec;73(6):1157-63
16079303
Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4495-9
11904379
Cell. 2005 Aug 12;122(3):473-83
16096065
Cell Stem Cell. 2009 Sep 4;5(3):332-42
19733544
Nat Methods. 2009 Jun;6(6):415-22
19478801
Mol Ther. 2009 Dec;17(12):2115-20
19809403
J Gene Med. 2007 May;9(5):403-15
17407189
Proc Natl Acad Sci U S A. 1985 Jul;82(13):4438-42
3892534
Genetics. 1998 May;149(1):179-87
9584095
Cell Biol Int. 2009 Apr;33(4):509-15
19353779
Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15008-13
17005721
Biol Reprod. 1995 Apr;52(4):709-20
7779992
Mol Ther. 2009 Jan;17(1):121-30
18985029